| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/24/2012 | WO2012066447A1 Compositions with antibacterial and wound healing activity |
| 05/24/2012 | WO2012066401A1 Stable oral pharmaceutical compositions of montelukast |
| 05/24/2012 | WO2012066347A1 Oil based formulations |
| 05/24/2012 | WO2012066334A1 Sonosensitive nanoparticles |
| 05/24/2012 | WO2012066257A1 Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria |
| 05/24/2012 | WO2012066256A1 Pharmaceutical composition comprising bicarbonate salt, and use thereof as a medicament in the treatment and/or prevention of urinary lithiasis and related diseases |
| 05/24/2012 | WO2012066254A1 Pharmaceutical composition comprising krebs cycle precursor salt, in particular citrate salt, and use thereof as a medicament |
| 05/24/2012 | WO2012066195A1 Method for preparing amide-initiated polymers having a varied architecture |
| 05/24/2012 | WO2012066171A1 Nanoparticles for the prevention and/or treatment of diseases of the mucus membranes |
| 05/24/2012 | WO2012066000A1 Intravaginal drug delivery device comprising a polyurethane copolymer |
| 05/24/2012 | WO2012065998A1 Polyurethane copolymer |
| 05/24/2012 | WO2012065751A1 Bio-functionalized stimulus-responsive dissolvable peg-hydrogels |
| 05/24/2012 | WO2012065740A1 Transdermal therapeutic system comprising buprenorphine |
| 05/24/2012 | WO2012065263A1 Immunogenic compositions |
| 05/24/2012 | WO2012065204A2 Vaginal suppository |
| 05/24/2012 | WO2012053006A8 Improved oral fast dissolving films comprising combination of polymers and method of preparation thereof |
| 05/24/2012 | WO2012038333A3 Composition to act in prevention and to take care of diabetic foot |
| 05/24/2012 | WO2012027247A3 Pharmaceutical composition of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration therof |
| 05/24/2012 | WO2012023024A3 Controlled release formulations of dronedarone |
| 05/24/2012 | WO2012022773A9 Probiotic composition for oral health |
| 05/24/2012 | WO2012012507A3 Methods, inserts, and systems useful for endodontic treatment |
| 05/24/2012 | WO2012010942A3 Novel pharmaceutical composition(s) of hiv protease inhibitor(s) |
| 05/24/2012 | WO2012008779A3 A liquid formulation of long-acting human growth hormone conjugate |
| 05/24/2012 | WO2012007570A3 New formulations of 14-epi-analogues of vitamin d |
| 05/24/2012 | WO2012006101A3 Blood substitutes and uses thereof |
| 05/24/2012 | WO2012001083A3 Novel eprinomectin injectable compositions |
| 05/24/2012 | WO2011151722A3 Methods and compositions for oral pharmaceutical therapy |
| 05/24/2012 | WO2011150284A3 Removal of serine proteases by treatment with finely divided silicon dioxide |
| 05/24/2012 | WO2011128337A3 Low-dosed solid oral dosage forms for hrt |
| 05/24/2012 | WO2011119288A3 Multilayer melt-extruded film |
| 05/24/2012 | WO2011086093A3 Pharmaceutical compositions for oral administration of insulin peptides |
| 05/24/2012 | WO2011069974A3 Polyurethane dispersions for sealing the teats of the mammary glands in milking animals |
| 05/24/2012 | WO2011012395A3 Foamable oil-water emulsion |
| 05/24/2012 | US20120130439 System and Method for Monitoring Power Source Longevity of an Implantable Medical Device |
| 05/24/2012 | US20120130435 Compositions and methods for arthrodetic procedures |
| 05/24/2012 | US20120130353 Medication infusion device using negatively biased ambient pressure medication chamber |
| 05/24/2012 | US20120130323 Delivery Product For Topical Compositions |
| 05/24/2012 | US20120130300 Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics |
| 05/24/2012 | US20120129823 Contraception process and administration form for the same |
| 05/24/2012 | US20120129134 Light-Curable Bone Growth Material for Treating Dental Bone Defects |
| 05/24/2012 | US20120128848 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 05/24/2012 | US20120128783 Compositions and methods for delivery of frozen particle adhesives |
| 05/24/2012 | US20120128782 Multicomponent Degradable Cationic Polymers |
| 05/24/2012 | US20120128781 Functionalization of nanoparticles by glucosamine derivatives |
| 05/24/2012 | US20120128780 Nanoparticulate bisphosphonate compositions |
| 05/24/2012 | US20120128779 Process for producing protein microparticles |
| 05/24/2012 | US20120128778 Compositions and methods for once-daily administration of a trilayer osmotic tablet |
| 05/24/2012 | US20120128777 Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles |
| 05/24/2012 | US20120128776 Method for the preparation of microparticles with efficient bioactive molecule incorporation |
| 05/24/2012 | US20120128775 Biocarrier and method of using the same |
| 05/24/2012 | US20120128774 Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix |
| 05/24/2012 | US20120128773 Desfesoterodine in the form of a tartaric acid salt |
| 05/24/2012 | US20120128772 Controlled release pharmaceutical compositions of milnacipran |
| 05/24/2012 | US20120128771 Timed, pulsatile release systems |
| 05/24/2012 | US20120128770 Treatment of insulin resistance and obesity by stimulating glp-1 release |
| 05/24/2012 | US20120128769 Solubilized CoQ-10 |
| 05/24/2012 | US20120128768 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 05/24/2012 | US20120128767 Therapeutic calcium phosphate particles and methods of making and using same |
| 05/24/2012 | US20120128766 Self-Breaking Tablets |
| 05/24/2012 | US20120128765 Method and device for producing soft capsules |
| 05/24/2012 | US20120128764 Controlled-release compositions comprising a proton pump inhibitor |
| 05/24/2012 | US20120128763 Lubricant for the ocular surface |
| 05/24/2012 | US20120128762 Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder Disorders |
| 05/24/2012 | US20120128761 Lipophilic Polynucleotide Conjugates |
| 05/24/2012 | US20120128760 Lipid compositions |
| 05/24/2012 | US20120128759 Method to inhibit airway hyperresponsiveness using aerosolized t cell receptor antibodies |
| 05/24/2012 | US20120128758 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies |
| 05/24/2012 | US20120128757 Method of Manufacture of Liposome Composition |
| 05/24/2012 | US20120128756 Skin Permeating And Cell Entering (SPACE) Peptides and Methods of Use Thereof |
| 05/24/2012 | US20120128755 Personal Care Composition Containing Yeast Extract And Hexapeptide |
| 05/24/2012 | US20120128754 Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid |
| 05/24/2012 | US20120128753 Meditowel pre-packaged medicated muscle and joint pain relief wipe |
| 05/24/2012 | US20120128752 Multi-phase microparticles and method of manufacturing multi-phase microparticles |
| 05/24/2012 | US20120128749 Composition and process for production thereof |
| 05/24/2012 | US20120128747 Core-shell material, method for preparing same, and use thereof for the thermostimulated generation of substances of interest |
| 05/24/2012 | US20120128744 Mixture containing menthol |
| 05/24/2012 | US20120128743 Polymer particles |
| 05/24/2012 | US20120128742 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein |
| 05/24/2012 | US20120128741 Modified hyaluronic acid polymer compositions and related methods |
| 05/24/2012 | US20120128740 Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them |
| 05/24/2012 | US20120128739 Three-dimensional nanostructured hybrid scaffold and manufacture thereof |
| 05/24/2012 | US20120128738 Theobromine for the Treatment of Cough |
| 05/24/2012 | US20120128737 Compositions for treating degenerative joint diseases |
| 05/24/2012 | US20120128736 Oil-in-water emulsion of mometasone |
| 05/24/2012 | US20120128735 Methods of treatment using a gastric retained gabapentin dosage |
| 05/24/2012 | US20120128734 Oral Delivery Product |
| 05/24/2012 | US20120128733 Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| 05/24/2012 | US20120128732 Combinations and modes of administration of therapeutic agents and combination therapy |
| 05/24/2012 | US20120128731 Biocompatible carrier and method for fabricating the same |
| 05/24/2012 | US20120128730 Compositions and methods for once-daily treatment of obsessive compulsive disorder with ondansetron |
| 05/24/2012 | US20120128729 Gallium Formulation For The Treatment And Prevention of Infectious Diseases |
| 05/24/2012 | US20120128728 Compositions Comprising Amphotericin B |
| 05/24/2012 | US20120128599 Oral care composition |
| 05/24/2012 | US20120128598 Topical Pharmaceutical Foam Composition |
| 05/24/2012 | US20120128595 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 05/24/2012 | US20120128592 Surface enhanced raman spectroscopy (sers) compounds and methods of their preparation |
| 05/24/2012 | US20120128590 Nanoparticle delivery systems for membrane-integrating peptides |
| 05/24/2012 | US20120128587 Folate-targeted diagnostics and treatment |
| 05/24/2012 | US20120128582 Methods and compositions of [32p]-labeled adenine nucleotides for the treatment of atherosclerosis, vascular arterial diseases and coronary artery diseases |
| 05/24/2012 | US20120125325 The use of amlexanox in the therapy of neutrophil-driven diseases |